Related Experiment Video
Updated: Aug 2, 2026

07:40
A Noninvasive Hair Sampling Technique to Obtain High Quality DNA from Elusive Small Mammals
Published on: March 13, 2011
Ultra-rapid DNA analysis using HyBeacon probes and direct PCR amplification from saliva
D J French1, C L Archard, M T Andersen
1BioAnalytical Innovations, LGC (Teddington) Ltd, Queens Road, Teddington, TW11 0LY, UK. dgf@lgc.co.uk
Molecular and Cellular Probes
|December 13, 2002
Summary
HyBeacons offer a novel homogeneous method for rapid genetic testing. This fluorescence-based probe technology enables accurate allele discrimination and genotyping from saliva in under 30 minutes for potential point-of-care applications.
Area of Science:
- Molecular Biology
- Genetics
- Biotechnology
Background:
- Fluorescence-based methods are crucial for genetic analysis.
- Allele discrimination and sequence detection require reliable and rapid technologies.
- Current methods can be time-consuming, involving DNA extraction and complex procedures.
Purpose of the Study:
- To introduce HyBeacons, a novel homogeneous probe technology.
- To demonstrate the utility of HyBeacons for rapid sequence analysis and allele discrimination.
- To enable non-invasive, point-of-care genetic testing.
Main Methods:
- Development of HyBeacon probes for homogeneous fluorescence-based detection.
- Utilizing a single nucleotide polymorphism in the N-acetyltransferase 2 gene as a model.
- Real-time PCR and melt peak analysis for DNA sequence detection and differentiation.
- Direct amplification from saliva samples without prior DNA extraction.
Main Results:
- HyBeacons provide a rapid and reliable method for sequence analysis.
- Accurate identification of homozygous and heterozygous samples using a single HyBeacon oligonucleotide.
- Genotyping achieved within 30 minutes through combined HyBeacon analysis, rapid thermal cycling, and direct saliva amplification.
Conclusions:
- HyBeacon technology offers a significant advancement in homogeneous, fluorescence-based genetic analysis.
- The method allows for rapid, non-invasive genotyping, facilitating point-of-care genetic testing.
- This technology has the potential to be implemented in clinical settings like hospitals and doctor's surgeries.

